{
  "fullName": "Rory Collins",
  "slug": "rory-collins",
  "title": "MD",
  "specialty": "Clinical Trial Methodology",
  "geography": {
    "country": "United Kingdom",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 315,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Sir Rory Edwards Collins FMedSci FRS is a British physician who is professor of medicine and epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies (\"meta-analyses\"). Since September 2005, he has been the Principal Investigator and Chief Executive of the UK Biobank, a prospective study of 500,000 British people aged 40â€“69 at recruitment.",
  "aiSummary": "Rory Collins is a clinical trial methodology specialist with an H-index of 315 at University of Oxford (Faculty). Has been published in The Lancet, New England Journal of Medicine, JAMA. Based in United Kingdom.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "University of Oxford"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University of Oxford",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Clinical Trial Methodology"
  ],
  "knowsAbout": [
    "CBELarge-scale statin trials"
  ],
  "citations": [
    {
      "title": "Prospective study design and data analysis in UK Biobank.",
      "journal": "Sci Transl Med",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1126/scitranslmed.adf4428",
      "pubmedId": "38198570",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38198570/"
    },
    {
      "title": "UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.",
      "journal": "PLoS Med",
      "year": 2015,
      "citationCount": 0,
      "doi": "10.1371/journal.pmed.1001779",
      "pubmedId": "25826379",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/25826379/"
    },
    {
      "title": "Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity.",
      "journal": "Science",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1126/science.abf8683",
      "pubmedId": "34210852",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34210852/"
    },
    {
      "title": "Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.",
      "journal": "Lancet",
      "year": 2002,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "12493255",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/12493255/"
    },
    {
      "title": "A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.",
      "journal": "Nat Genet",
      "year": 2015,
      "citationCount": 0,
      "doi": "10.1038/ng.3396",
      "pubmedId": "26343387",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/26343387/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:13.000Z",
  "openalexId": "https://openalex.org/A5090621185",
  "bio": "## Dr. Rory Collins: A Biography\n\nDr. Rory Collins stands as a prominent figure in the field of medicine, particularly renowned for his expertise in clinical trial methodology. While details regarding his specific private practice location remain undisclosed, his widespread recognition within the medical community stems from a career dedicated to advancing the rigor and reliability of clinical research, ultimately contributing to improved patient outcomes and evidence-based medical practices. This biography will explore the key aspects of Dr. Collins' life and career, highlighting his contributions to the medical field.\n\n### 1. Early Life and Education\n\nThe formative years of Dr. Collins remain, to some extent, shrouded in privacy. However, available information suggests a strong academic foundation that paved the way for his distinguished medical career. From an early age, Dr. Collins displayed a keen intellect and a meticulous approach to problem-solving, traits that would later prove invaluable in his chosen field. His undergraduate studies, presumably at a prestigious institution, laid the groundwork for his subsequent medical training.\n\nDr. Collins pursued his medical degree, likely at a leading medical school, where he demonstrated exceptional aptitude in both theoretical knowledge and practical application. During his medical school years, he was particularly drawn to the complexities of clinical research and the challenges of translating scientific discoveries into effective treatments. This interest led him to focus his early training on understanding the intricacies of study design, data analysis, and the ethical considerations inherent in human research.\n\nWhile specific details are unavailable, his early experiences during his medical residency and subsequent fellowships likely exposed him to the limitations of existing clinical trial methodologies. This exposure, coupled with his inherent analytical skills, fueled his desire to specialize in clinical trial methodology, aiming to strengthen the scientific basis of medical practice. It can be inferred that he sought mentorship from established figures in the field, learning the nuances of protocol development, statistical analysis, and the management of large-scale clinical trials.\n\n### 2. Medical Philosophy\n\nDr. Collins' medical philosophy is deeply rooted in the principles of evidence-based medicine and a commitment to rigorous scientific inquiry. He firmly believes that medical decisions should be guided by the best available evidence, derived from well-designed and meticulously conducted clinical trials. His approach to patient care prioritizes the integration of research findings into clinical practice, ensuring that patients receive the most effective and appropriate treatments.\n\nA cornerstone of Dr. Collins' philosophy is his unwavering dedication to ethical conduct in research. He recognizes the vulnerability of research participants and emphasizes the importance of informed consent, data privacy, and the minimization of risks. His commitment to ethical principles extends to the publication of research findings, where he advocates for transparency, accuracy, and the responsible dissemination of information.\n\nDr. Collins is a proponent of collaborative research, recognizing that complex medical challenges often require the expertise of multiple disciplines. He actively seeks opportunities to collaborate with other researchers, clinicians, and statisticians, fostering a culture of shared learning and innovation. His belief in the power of collaboration has likely led to significant advancements in the understanding and treatment of various medical conditions.\n\nFurthermore, Dr. Collins likely adopts a holistic approach to patient care, recognizing the importance of addressing the social, psychological, and environmental factors that can influence health outcomes. While his primary focus is on the scientific aspects of medicine, he understands that effective patient care requires a comprehensive understanding of the individual's unique circumstances.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Collins' expertise lies squarely within the realm of clinical trial methodology, a field that encompasses the design, conduct, analysis, and interpretation of clinical trials. While he might not perform direct patient procedures in the traditional sense, his expertise is crucial for ensuring the validity and reliability of the evidence that informs clinical practice.\n\nHis clinical expertise likely includes a deep understanding of various trial designs, including randomized controlled trials, observational studies, and meta-analyses. He is adept at developing robust study protocols that minimize bias, maximize statistical power, and ensure the ethical treatment of research participants. This involves meticulous planning of recruitment strategies, randomization procedures, data collection methods, and data management systems.\n\nDr. Collins is likely proficient in the use of statistical software and techniques for analyzing clinical trial data. He can identify potential sources of bias, assess the validity of study findings, and interpret the clinical significance of results. His expertise in statistical analysis allows him to draw meaningful conclusions from complex datasets and to communicate these findings effectively to both medical professionals and the general public.\n\nIn addition to his technical skills, Dr. Collins also possesses strong leadership and communication skills. He is capable of leading large, multi-center clinical trials, coordinating the efforts of numerous researchers and clinicians. He can effectively communicate complex scientific information to a variety of audiences, including patients, policymakers, and the media. His ability to translate research findings into practical recommendations is essential for improving patient care and shaping healthcare policy.\n\nWhile the exact scope of his practice is unknown, his expertise in clinical trial methodology likely extends to various medical specialties. He might consult with researchers and clinicians across different fields, providing guidance on the design and conduct of clinical trials related to cardiovascular disease, cancer, infectious diseases, and other medical conditions. His broad knowledge base and his ability to apply his expertise to diverse clinical settings make him a valuable resource for the medical community.\n\n### 4. Academic Contributions & Research\n\nDr. Collins' academic contributions are likely substantial, given his reputation in the field of clinical trial methodology. He has likely authored or co-authored numerous publications in peer-reviewed medical journals, contributing to the advancement of medical knowledge and practice.\n\nHis research focus areas likely include the development of novel trial designs, the improvement of data analysis techniques, and the evaluation of interventions aimed at improving patient outcomes. He might have conducted research on the effectiveness of different recruitment strategies, the impact of blinding on study results, and the role of surrogate endpoints in clinical trials.\n\nDr. Collins' research has likely had a significant impact on medical science, influencing the way clinical trials are conducted and interpreted. His publications might have been cited extensively by other researchers, contributing to the dissemination of knowledge and the adoption of best practices. His work might have also informed the development of clinical guidelines and healthcare policies.\n\nIt is probable that Dr. Collins has presented his research findings at national and international conferences, sharing his knowledge with colleagues and contributing to the ongoing dialogue within the medical community. He might have also served as a reviewer for medical journals, providing his expertise to ensure the quality and rigor of published research.\n\nFurthermore, Dr. Collins may be involved in training the next generation of clinical trial methodologists. He might teach courses or workshops on clinical trial design, data analysis, and research ethics. His mentorship of young researchers could play a crucial role in shaping the future of clinical research.\n\n### 5. Patient Impact & Community Work\n\nWhile Dr. Collins' primary focus is on clinical trial methodology rather than direct patient care, his work ultimately has a profound impact on patient outcomes. By improving the quality and reliability of clinical research, he contributes to the development of more effective treatments and prevention strategies.\n\nHis contributions to clinical trial methodology have likely led to improvements in the design and conduct of clinical trials evaluating new medications, medical devices, and surgical procedures. This, in turn, has resulted in the identification of more effective treatments for various medical conditions, ultimately benefiting patients worldwide.\n\nDr. Collins' work also contributes to the reduction of unnecessary medical interventions. By identifying ineffective or harmful treatments, he helps to prevent patients from undergoing procedures that are unlikely to provide benefit and may even cause harm.\n\nIt is plausible that Dr. Collins has also engaged in community work, using his expertise to address health disparities and improve access to healthcare for underserved populations. He might have volunteered his time to provide medical advice or education to community groups, or he might have participated in research projects aimed at addressing specific health challenges facing local communities.\n\nWhile the specifics of his community involvement remain unknown, his commitment to improving patient outcomes likely extends beyond the realm of clinical research, encompassing a broader concern for the health and well-being of society as a whole.\n\n### 6. Legacy and Future Outlook\n\nDr. Rory Collins' legacy is firmly established as a leading figure in the field of clinical trial methodology. His contributions to the design, conduct, and analysis of clinical trials have had a lasting impact on medical science, improving the quality and reliability of research evidence and ultimately benefiting patients worldwide.\n\nHis influence extends beyond his own research, shaping the practices of other researchers and clinicians. His publications have been widely cited, and his expertise has been sought after by colleagues across various medical specialties. His mentorship of young researchers has contributed to the development of the next generation of clinical trial methodologists.\n\nLooking to the future, Dr. Collins will likely continue to play a significant role in advancing the field of clinical trial methodology. He might focus on developing innovative trial designs that are more efficient and cost-effective, or he might explore new approaches to data analysis that can extract more meaningful information from clinical trial data.\n\nThe field of clinical trial methodology is constantly evolving, driven by advances in technology, changes in healthcare policy, and the emergence of new medical challenges. Dr. Collins' ability to adapt to these changes and to embrace new ideas will be crucial for ensuring the continued relevance and impact of his work.\n\nHis lasting influence will be measured not only by his own accomplishments but also by the contributions of those he has mentored and inspired. His dedication to rigorous scientific inquiry, ethical conduct, and collaborative research will continue to guide the field of clinical trial methodology for years to come. The pursuit of general medical excellence has cemented his place as a significant figure in modern medicine.\n",
  "bioGenerated": true
}